-
Osteonecrosis of the jaw and bisphosphonates.
PMID: 16000365 [PubMed - indexed for MEDLINE]
-
Cited by 14 PubMed Central articles
-
Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.
Borgioli A, Viviani C, Duvina M, Brancato L, Spinelli G, Brandi ML, Tonelli P.
Ther Clin Risk Manag. 2009 Feb; 5(1):217-27. Epub 2009 Mar 26.
[Ther Clin Risk Manag. 2009]
-
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, et al.
Cancer Invest. 2009 Feb; 27(2):221-6.
[Cancer Invest. 2009]
-
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.
Devitt B, McLachlan SA.
Ther Clin Risk Manag. 2008 Apr; 4(2):453-8.
[Ther Clin Risk Manag. 2008]
- » See all...